Literature DB >> 8491061

The use of caffeine for enzyme assays: a critical appraisal.

W Kalow1, B K Tang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8491061     DOI： 10.1038/clpt.1993.63

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  57 in total

1.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

2.  Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS.

Authors:  W M O'Neil; J C Pezzullo; A Di Girolamo; C M Tsoukas; I W Wainer
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

3.  Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo.

Authors:  J T Larsen; L L Hansen; K Brosen
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

5.  Why dried blood spots are an ideal tool for CYP1A2 phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

6.  Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

Authors:  H J M van Kan; G J Groeneveld; S Kalmijn; M Spieksma; L H van den Berg; H J Guchelaar
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

7.  NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.

Authors:  A Nyéki; T Buclin; J Biollaz; L A Decosterd
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

8.  Induction of P-450 in workers exposed to dioxin.

Authors:  W Halperin; W Kalow; M H Sweeney; B K Tang; M Fingerhut; B Timpkins; K Wille
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

9.  Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.

Authors:  L J Notarianni; S E Oliver; P Dobrocky; P N Bennett; B W Silverman
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  Does long-term coffee intake reduce type 2 diabetes mellitus risk?

Authors:  Gustavo D Pimentel; Juliane Cs Zemdegs; Joyce A Theodoro; João F Mota
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.